产品封面图
文献支持

化合物 GSK583【1346547-00-9】

收藏
  • ¥341 - 9520
  • TargetMol
  • T3537
  • 2026年07月07日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • CAS号

      1346547-00-9

    • 规格

      1mLx10mM(inDMSO)/1mg/2mg/5mg/10mg/25mg/50mg/100mg/500mg

    规格:1mLx10mM(inDMSO)产品价格:¥778.0
    规格:1mg产品价格:¥341.0
    规格:2mg产品价格:¥495.0
    规格:5mg产品价格:¥928.0
    规格:10mg产品价格:¥1296.0
    规格:25mg产品价格:¥2264.0
    规格:50mg产品价格:¥3416.0
    规格:100mg产品价格:¥4784.0
    规格:500mg产品价格:¥9520.0

    Product Introduction

    Bioactivity

    名称 GSK583
    描述 GSK583 is a highly effective and specific RIP2 kinase inhibitor (IC50: 5 nM).
    细胞实验 To assess cellular selectivity, monocytes are pretreated with inhibitor for 30 min, then stimulated for 6 h with ligands which selectively agonize NLRs NOD1, NOD2; Toll-like receptors TLR, TLR4, TLR7, or cytokine receptors IL-1R, TNFR. Release of pro-inflammatory cytokines, either TNFα (NOD2, TLR2, TLR4, IL1R) or IL-8 (NOD1, TLR7, TNFR), is measured by immunoassay. Percent inhibition and/or IC50 values are calculated. (Only for Reference)
    激酶实验 A fluorescent polarization based binding assay is developed to quantitate interaction of novel test compounds at the ATP binding pocket of RIP2K by competition with a fluorescently labeled ATP competitive ligand. Full length FLAG His tagged RIP2K is purified from a baculovirus expression system and is used at a final assay concentration of twice the KD apparent. A fluorescent labeled ligand that is reversible and competitive with the inhibitors is used at a final assay concentration of 5 nM. Both the enzyme and ligand are prepared in solutions in 50 mM HEPES pH 7.5, 150 mM NaCl, 10 mM MgCl2, 1 mM DTT, and 1 mM CHAPS. Test compounds are prepared in 100% DMSO, and 100 nL is dispensed to individual wells of a multiwell plate. Next, 5 μL of RIP2K is added to the test compounds at twice the final assay concentration and incubated at room temperature for 10 min. Following the incubation, 5 μL of the fluorescent labeled ligand solution is added to each reaction at twice the final assay concentration and incubated at room temperature for at least 10 min. Finally, samples are read on an instrument capable of measuring fluorescent polarization. Test compound inhibition is expressed as percent (%) inhibition of internal assay controls. For concentration response experiments, normalized data are fit using the following four parameter logistic equation: y = A + ((B-C))/(1+(10x)/(10C)D), where y is the % activity (% inhibition) at a specified compound concentration, A is the minimum % activity, B is the maximum % activity, C = log10(IC50), D = Hill slope, x = log10(compound concentration [M]), and pIC50 = (?C).
    体外活性 GSK583 possesses a comparable binding affinity for RIP3 kinase similarly to the RIP2 (RIP2/3 FP IC50: 5/16 nM) by an in-house FP binding assay configured. But GSK583 (10 μM) shows little or no inhibition of RIP3-dependent necroptotic cell death in a cellular assay. GSK583 effectively and dose-dependently inhibits MDP-stimulated TNFα production (IC50: 8 nM) in primary human monocytes. Following treatment with GSK583 at 1 μM, little inhibition of pro-inflammatory signaling is observed upon activation of cytokine receptors (IL-1R, TNFR) or Toll-like receptors (TLR2, TLR4, TLR7) but complete inhibition is observed upon activation of NOD1/2 receptors, which signal in a RIP2-dependent manner. Although it has excellent kinase selectivity, GSK583 does inhibit both the hERG channel and CYP3A4.
    体内活性 GSK583 has moderate volumes of distribution, low clearance, and moderate oral bioavailability (in rat and mouse). Although GSK583 would not produce a human pharmacodynamic response within an acceptable dose range, the oral PK in mouse and rat supplies enough systemic exposure for use as a preclinical in vivo tool molecule in an acute inflammation challenge model.
    存储条件 Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
    溶解度 DMSO : 45 mg/mL (112.94 mM), Sonication is recommended.
    H2O : < 1 mg/mL (insoluble or slightly soluble)
    Ethanol : 27 mg/mL (67.76 mM), Sonication is recommended.
    10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (5.02 mM), Sonication is recommended.
    关键字 RIPkinase | RIPK | RIP3 | RIP1 | RIP kinase | Receptor-interacting protein kinases | Inhibitor | inhibit | GSK-583 | GSK583 | GSK 583
    相关产品 Necrostatin-34 | RIPK2-IN-3 | GSK2983559 free acid | Apostatin-1 | Necrostatin-1 | LY-364947 | Necroptosis-IN-1 | RIPA-56 | Oditrasertib | PK68 | ICCB-19 hydrochloride | RIPK2-IN-5
    相关库 Inhibitor Library | Immuno-Oncology Compound Library | Bioactive Compound Library | Anti-Cancer Compound Library | Bioactive Compounds Library Max | Kinase Inhibitor Library | Anti-Aging Compound Library | Antidepressant Compound Library | Immunology/Inflammation Compound Library | NF-κB Signaling Compound Library | Target-Focused Phenotypic Screening Library | Anti-Prostate Cancer Compound Library

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    官网有文献
    相关实验
    •  杂环化合物和生物碱-- 杂环化合物

      网络 第十九章 杂环化合物和生物碱 杂环化合物在自然界分布很广,其数量几乎占已知有机化合物的三分之一,用途也很多。许多重要的物质如叶绿素、血红素、核酸以及临床应用的一些有显著疗效的天然药物和合成药物等,都含有杂环化合物的结构。生物碱多是中草药的有效成分,绝大多数是含氮的杂环化合物。本章内容与医学关系密切,具有重要意义。

    • 高能化合物 energy rich compound

          分子中具有高能键的化合物。在生物体内主要有上式(Ⅰ)和(Ⅱ)两种结构的高能化合物。其作用为贮藏能量(例如 ATP、肌酸磷酸)和作为产生 ATP源的中间代谢产物(例如磷酸烯醇丙酮酸)以及合成反应的中间物质(例如酰基辅酶 A),在蛋白质的结构( conformation)变化周期的第一阶段上(例如钠钾 ATP酶的羧基磷酸中间体)也具有重要作用。多数高等化合物具有磷酸基,但也有例外。  

    • 化合物

      由不同种元素组成的纯净物叫做化合物化合物一般有固定的组成。化合物的组成一般可用化学式表示。化合物具有确定的物理性质和化学性质,不同于其组成元素的性质。化合物中的元素不能用简单的机械方法或物理方法分开,而必须用化学方法才能分离。    

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥836.54
    北京德航五洲科技有限公司
    2025年07月15日询价
    ¥534
    MedChemExpress LLC
    2025年12月05日询价
    ¥1235
    爱必信(上海)生物科技有限公司
    2025年07月14日询价
    ¥495
    北京沃比森科技有限公司
    2025年11月05日询价
    ¥427
    TargetMol中国
    2025年07月07日询价
    文献支持
    化合物 GSK583【1346547-00-9】
    ¥341 - 9520